These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators. Kremoser C; Albers M; Burris TP; Deuschle U; Koegl M Drug Discov Today; 2007 Oct; 12(19-20):860-9. PubMed ID: 17933688 [TBL] [Abstract][Full Text] [Related]
4. Ligand specificity of nuclear hormone receptors: sifting through promiscuity. Noy N Biochemistry; 2007 Nov; 46(47):13461-7. PubMed ID: 17983246 [TBL] [Abstract][Full Text] [Related]
6. Overview of nomenclature of nuclear receptors. Germain P; Staels B; Dacquet C; Spedding M; Laudet V Pharmacol Rev; 2006 Dec; 58(4):685-704. PubMed ID: 17132848 [TBL] [Abstract][Full Text] [Related]
7. The flip side: Identifying small molecule regulators of nuclear receptors. Schulman IG; Heyman RA Chem Biol; 2004 May; 11(5):639-46. PubMed ID: 15157874 [TBL] [Abstract][Full Text] [Related]
8. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design. Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255 [TBL] [Abstract][Full Text] [Related]
9. Nuclear hormone receptor assays for drug discovery. Rosen J; Marschke K; Rungta D Curr Opin Drug Discov Devel; 2003 Mar; 6(2):224-30. PubMed ID: 12669458 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling. Pearce KH; Iannone MA; Simmons CA; Gray JG Drug Discov Today; 2004 Sep; 9(17):741-51. PubMed ID: 15450240 [TBL] [Abstract][Full Text] [Related]
11. Digging deep into the pockets of orphan nuclear receptors: insights from structural studies. Benoit G; Malewicz M; Perlmann T Trends Cell Biol; 2004 Jul; 14(7):369-76. PubMed ID: 15246430 [TBL] [Abstract][Full Text] [Related]
12. Ligand-based approach to in silico pharmacology: nuclear receptor profiling. Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212 [TBL] [Abstract][Full Text] [Related]
13. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Smith CL; O'Malley BW Endocr Rev; 2004 Feb; 25(1):45-71. PubMed ID: 14769827 [TBL] [Abstract][Full Text] [Related]
14. Computational chemistry approaches to drug discovery in signal transduction. Fischer PM Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174 [TBL] [Abstract][Full Text] [Related]
15. A fluorescent indicator to visualize ligand-induced receptor/coactivator interactions for screening of peroxisome proliferator-activated receptor gamma ligands in living cells. Awais M; Sato M; Umezawa Y Biosens Bioelectron; 2007 May; 22(11):2564-9. PubMed ID: 17095203 [TBL] [Abstract][Full Text] [Related]
16. Development of assays for nuclear receptor modulators using fluorescently tagged proteins. Martinez ED; Hager GL Methods Enzymol; 2006; 414():37-50. PubMed ID: 17110185 [TBL] [Abstract][Full Text] [Related]
18. Structure and function of the atypical orphan nuclear receptor small heterodimer partner. Lee YS; Chanda D; Sim J; Park YY; Choi HS Int Rev Cytol; 2007; 261():117-58. PubMed ID: 17560281 [TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors: one big family. McEwan IJ Methods Mol Biol; 2009; 505():3-18. PubMed ID: 19117136 [TBL] [Abstract][Full Text] [Related]
20. Design of selective nuclear receptor modulators: RAR and RXR as a case study. de Lera AR; Bourguet W; Altucci L; Gronemeyer H Nat Rev Drug Discov; 2007 Oct; 6(10):811-20. PubMed ID: 17906643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]